Blackburn, Edith <br/><br/>
A monoclonal antibody to the human HER3 receptor inhibits Neuregulin 1-beta binding and co-operates with Herceptin in inhibiting the growth of breast cancer derived cell lines.  [electronic resource] 

 -  Breast cancer research and treatment  Jul 2012 
 - 53-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-011-1908-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--pharmacology<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Binding, Competitive<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor--drug effects<br/>Cell Proliferation--drug effects<br/>Drug Screening Assays, Antitumor<br/>Drug Synergism<br/>Female<br/>Humans<br/>Neuregulin-1--metabolism<br/>Protein Binding<br/>Receptor, ErbB-3--antagonists & inhibitors<br/>Trastuzumab